2016 American Transplant Congress
Impact of Early Acute Rejection (AR) on Pancreas Transplant (PT) Outcomes.
University of Minnesota, Minneapolis.
Background: The role of early AR in long-term PT outcomes remains unclear. Despite reported high rate of AR (up to 40% in PTA), graft survival…2016 American Transplant Congress
Antibody-Mediated Rejection in Pancreas Transplantation.
PURPOSE: The diagnostic criteria for antibody-mediated rejection (AMR) in pancreas transplantation (PTx) is evolving. The incidence and long-term effect of AMR have not been well-described.…2016 American Transplant Congress
Conversion from Tacrolimus to Belatacept in Pancreas Transplant Alone Recipients with Chronic Kidney Disease.
Medicine/Nephrology & Surgery/Transplant, Indiana University, Indianapolis.
Background: CNI toxicity is a well known risk factor for chronic kidney disease and ESRD in organ transplants. We report our experience in converting Pancreas…2016 American Transplant Congress
Incidence and Indications for Pancreatectomy After Late Pancreas Allograft Failure.
University of Wisconsin School of Medicine and Public Health, Madison, WI.
There is little information about incidence, indications and risk factors for late allograft pancreatectomy (PTX) in patients with ongoing immunosuppression for a functional kidney allograft.We…2016 American Transplant Congress
Pancreas After Islet Transplantation – A Successful Treatment Option After a Failed Islet Transplant.
Department of Surgery, SUNY Upstate Medical University, Syracuse, NY.
Introduction: Pancreas after islet (PAI) transplantation (tx) is a treatment option for patients seeking insulin independence through a whole organ transplant after a previous, failed…2016 American Transplant Congress
Combination of Delayed Kidney Transplant (KT) and Better Quality Kidneys Offers Excellent Patient Survival in Combined Liver-Kidney Transplantation (CLKT).
Transplant Division, Department of Surgery, Indiana University, Indianapolis, IN.
Background: Despite prioritizing high MELD patients with the share-35 policy, patient survival in CLKT is relatively low. We previously showed the positive impact of delayed…2016 American Transplant Congress
The Effect of DRI and KDPI on Outcomes of High MELD Patients Undergoing Simultaneous Liver Kidney Transplant.
Background: Patients with a high Model for End Stage Liver Disease (MELD) score have an increased risk for dying without transplant. Renal function worsens secondary…2016 American Transplant Congress
Utility in Treating Renal Failure in End-Stage Liver Disease with Simultaneous Liver-Kidney Transplantation.
The number of simultaneous liver-kidney transplants (SLKT) for end-stage liver disease (ESLD) with renal failure is rising. The overall utility of kidneys used in this…2016 American Transplant Congress
Acute Kidney Injury After Liver Transplantation Is Set in Motion Early After Reperfusion of the Liver Graft: A Prospective Cohort Study.
Objective: Determine creatinine changes during liver transplantation and risk factors for acute kidney injury (AKI) in a prospective cohort study (NCT01333319).Background Data: AKI, a major…2016 American Transplant Congress
AT1R Antibodies at 1-Year Negatively Impact 5-Year Native Renal Function in Liver Transplant Recipients.
Angiotensin II Type-1 Receptor (AT1R) antibodies have been associated with pulmonary hypertension, renal allograft loss, and fibrosis progression in liver allograft recipients especially if combined…
American Transplant Congress abstracts